Laxmi Dental Share News - Latest Updates, Live News & More

Latest news about Laxmi Dental

Laxmi Dental Limited Clarifies Trading Volume Surge to Stock Exchanges 6 days ago

Laxmi Dental Limited responded to NSE's inquiry about increased trading volume on January 20, 2026, clarifying that no unpublished price sensitive information exists and the volume surge is market-driven. The company reaffirmed its compliance with SEBI LODR Regulations and confirmed all necessary disclosures have been made to stock exchanges.

Laxmi Dental Lock-in Period Ends: 7.1 Million Shares Worth ₹167 Crores Become Tradeable 7 days ago

Laxmi Dental Board Addresses NSE Fine and Appoints New Company Secretary 10 days ago

H.G. Infra Engineering's Joint Statutory Auditor Converts to LLP Structure 10 days ago

Laxmi Dental Limited Enters ₹50 Lakh Loan Agreement with Subsidiary Signature Smiles Dental Clinic Dec 29, 2025

More news about Laxmi Dental

18Nov 25

Laxmi Dental Reports Strong Q2FY26 Performance with 26.5% Revenue Growth

Laxmi Dental Limited reported robust Q2 FY26 results with revenue increasing 26.5% year-on-year to Rs. 72.00 crores. EBITDA margin was maintained at 15.3%, while PAT margin stood at 11.8%. The company's core dental laboratory business grew by 29.9%, with international lab business surging 39.2%. Digital dentistry push resulted in 94.7% growth in scanner sales. The aligner solutions segment grew by 12.3%, with Vedia showing strong 29.9% growth. Management remains confident in maintaining growth trajectory and meeting full-year revenue guidance of 20-25% growth and 13-15% PAT margins for FY26.

13Nov 25

Laxmi Dental Projects Strong Growth: Targets 20-25% Revenue Increase and 13-15% PAT Margins for FY26

Laxmi Dental Limited anticipates 20-25% revenue growth and 13-15% PAT margins for FY26. H1 FY26 saw PAT margins at 12.2%, with expectations of stronger H2 performance. The company aims for a long-term EBITDA margin of at least 20%. Q2 FY26 results show revenue of ₹722.65 million and PAT of ₹75.57 million. Strategic investments include stakes in IDBG AI Dent Global, increased investment in US subsidiary, and additional shares in Bizdent Devices. Management remains optimistic despite potential global uncertainties.

11Nov 25

Laxmi Dental Reports 26.5% Revenue Growth in Q2FY26 with Strong Scanner Sales Performance

Laxmi Dental Limited reported robust Q2 FY26 results with revenue growing 26.5% year-over-year to ₹723.00 million. EBITDA and PAT margins were maintained at 15.3% and 10.5% respectively. Scanner sales surged 94.7%, dental lab business grew 29.9%, and aligner solutions increased by 12.3%. The company continues to focus on automation, R&D, brand building, digital dentistry, and AI innovation.

19Sept 25

Laxmi Dental Limited Finalizes Strategic Acquisition in IDBG AI Dent Global

Laxmi Dental Limited has finalized its acquisition of stakes in IDBG AI Dent Global Private Limited. The company acquired a 49% equity stake for ₹1.37 crore and 9% stake in preference shares for ₹62.88 lakh. This move strengthens Laxmi Dental's position in AI-driven dental technology. The company also announced a scheduled meeting with investors and analysts in Mumbai.

12Aug 25

Laxmi Dental Reports Strong Q1 FY26 Results, Plans Global Expansion

Laxmi Dental, India's leading integrated dental products company, reported robust Q1 FY26 results with a 9.9% YoY increase in consolidated revenue to ₹656.00 crore. EBITDA stood at ₹119.10 crore with an 18.2% margin, while PAT reached ₹83.30 crore. The company announced global expansion plans focusing on clear aligners, digital dentistry, and exports. Laxmi Dental is also venturing into AI-powered dentistry solutions. The company provided an update on its IPO proceeds utilization, with ₹658.02 crore remaining unutilized and temporarily invested in fixed deposits.

12Aug 25

Laxmi Dental Limited Reports Strong Q1 FY25-26 Results with 83.30 Crore Profit

Laxmi Dental Limited announced robust Q1 FY25-26 results with consolidated sales of Rs. 643.21 crore and profit after tax of Rs. 83.30 crore. Standalone sales reached Rs. 496.24 crore with Rs. 78.59 crore profit. The company's three business segments performed well: Laboratory (Rs. 445.94 crore), Aligners (Rs. 187.26 crore), and Other Business (Rs. 26.17 crore). Basic EPS stood at Rs. 1.53. The Board re-appointed M/s. S.H.B.A & Co. LLP as Internal Auditor and approved in-principle acquisition of a stake in IDBG Al Dent Global Private Limited.

07Aug 25

Laxmi Dental Limited Announces Q1 FY26 Earnings Conference Call for August 13

Laxmi Dental has scheduled an earnings conference call on August 13, 2025, at 12:00 Noon IST to discuss Q1 FY26 financial results. Key executives participating include the Chairperson, CEO, and CFO. The company has also announced a board meeting on August 12, 2025, to approve the unaudited financial results. The trading window for company securities has been closed since July 1, 2025, and will reopen 48 hours after the results declaration.

28Jul 25

Laxmi Dental Expands into AI Dentistry with 58% Stake Acquisition in AI Dent Global

Laxmi Dental Limited has approved the acquisition of a 58% stake in IDBG AI Dent Global Private Limited (AI Dent), a DPIIT-recognized startup, for Rs 2.05 crore. The investment includes purchasing equity shares and subscribing to compulsorily convertible preference shares. AI Dent specializes in AI-powered dental image analysis and X-ray analysis software. The deal is expected to be completed by September 30, 2025. Additionally, Laxmi Dental has reconstituted its Nomination and Remuneration Committee with three independent directors.

21Jul 25

Laxmi Dental's Lock-in Period Ends, Freeing Up 37% of Shares for Trading

Laxmi Dental's six-month shareholder lock-in period has ended, making 2.06 crore shares (37% of equity) eligible for trading. Promoters hold 41.70% stake, followed by mutual funds at 11.89%, foreign institutions at 6.68%, and retail shareholders at 4.50%. Key investors include HSBC, HDFC, Invesco Mutual Funds, Abu Dhabi Investment Authority, and Goldman Sachs. Motilal Oswal initiated coverage with a 'buy' recommendation, projecting a 26% upside. The stock rose 12%, closing at ₹484.00, above its IPO price of ₹428.00 but still 17% below its post-listing high.

27May 25

Laxmi Dental Reports Mixed Q4 Results: Revenue Up, Profit Down

Laxmi Dental's Q4 financial results show a 10.62% increase in consolidated revenue to 604.00 million rupees. However, net profit declined by 42.67% to 43.00 million rupees. EBITDA decreased to 96.00 million rupees, with the EBITDA margin dropping to 15.84% from 21.30% year-over-year. The company faces challenges in maintaining profitability despite revenue growth.

28Apr 25

Laxmi Dental Invests ₹40.91 Crore in Subsidiary Bizdent Devices, Signaling Expansion in Dental Industry

Laxmi Dental Limited is investing ₹40.91 crore in its wholly-owned subsidiary, Bizdent Devices Private Limited (BDPL), through a rights issue of 8,93,334 equity shares at ₹458 per share. The funds will be used for debt repayment and capital expenditure on new machinery. BDPL, incorporated in 2021, manufactures dental products and has shown significant growth, with turnover increasing from ₹4.95 crore in FY 2021-22 to ₹37.58 crore in FY 2023-24. The investment aligns with Laxmi Dental's recent financial growth, despite some cash flow challenges.

17Apr 25

Laxmi Dental to Boost Stake in US Subsidiary with $1 Million Investment

Laxmi Dental Limited plans to invest up to $1 million to increase its stake in its US-based subsidiary, Laxmi Dental Lab USA Inc., from 55.56% to 71.43%. The company will acquire 10,000 additional equity shares at $100 each, based on an Investment Agreement dated December 24, 2024. This strategic move aims to strengthen Laxmi Dental's presence in the American dental prosthetics market. The company has obtained RBI approval for the overseas investment, complying with foreign exchange regulations.

16Apr 25

Laxmi Dental to Invest $1 Million in US Subsidiary, Boosting Ownership Stake

Laxmi Dental Limited plans to invest up to $1 million to increase its ownership in Laxmi Dental Lab USA Inc. from 55.56% to 71.43%. The company will acquire 10,000 equity shares at $100 per share, with RBI approval obtained for fund transfer. This strategic move aims to strengthen Laxmi Dental's presence in the US dental prosthetics market and capitalize on industry growth trends.